Portland, Oregon
CNS trials open to children and teens in Portland, OR
8 CNS studies open to children and teens are recruiting participants at sites in Portland as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Portland at a glance
- 8 studies are recruiting at a site in Portland.
- By phase: Phase 1/2 (1), Phase 3 (5), Phase 4 (1), No phase (1). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (7), university, hospital or other (1).
- By research area: Migraine (4), ADHD (3), Epilepsy (1).
- Most recent update to one of these records: November 6, 2026.
ADHD studies recruiting in Portland
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717892 · updated
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
- No phase
- Ages 6 to 17
- All sexes
- Sponsor
- Oregon Health and Science University
- Study site
- Oregon Health & Science University
- Registry record
- NCT06133231 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Portland, OR on ClinicalTrials.gov.
Epilepsy studies recruiting in Portland
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Encoded Therapeutics
- Study site
- Oregon Health and Science University (OHSU)
- Registry record
- NCT05419492 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Portland, OR on ClinicalTrials.gov.
Migraine studies recruiting in Portland
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Providence Neuroscience Institute - Research Coordinator's Office · Providence St. Vincent Medical Center
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Providence Neuroscience Institute: Research Coordinators' Office · Providence Pediatric Specialty Clinic
- Registry record
- NCT04743141 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Providence Brain and Spine Institute /ID# 231607
- Registry record
- NCT05125302 · updated
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Phase 4
- Ages 6 to 11
- All sexes
- Sponsor
- Upsher-Smith Laboratories
- Study site
- Upsher-Smith Clinical Trial Site #6
- Registry record
- NCT04748601 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Portland, OR on ClinicalTrials.gov.
Ask about studies near Portland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections